nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—PTGS2—atherosclerosis	0.141	1	CbGaD
Etoposide—ABCC3—Ezetimibe—atherosclerosis	0.0688	0.11	CbGbCtD
Etoposide—UGT1A1—Ezetimibe—atherosclerosis	0.0514	0.0824	CbGbCtD
Etoposide—UGT1A1—Simvastatin—atherosclerosis	0.0478	0.0766	CbGbCtD
Etoposide—UGT1A1—Lovastatin—atherosclerosis	0.0467	0.0749	CbGbCtD
Etoposide—ABCC1—Rosuvastatin—atherosclerosis	0.0422	0.0677	CbGbCtD
Etoposide—ABCC2—Ezetimibe—atherosclerosis	0.0313	0.0501	CbGbCtD
Etoposide—ABCC2—Simvastatin—atherosclerosis	0.0291	0.0466	CbGbCtD
Etoposide—ABCC2—Lovastatin—atherosclerosis	0.0284	0.0456	CbGbCtD
Etoposide—ABCC2—Pravastatin—atherosclerosis	0.0284	0.0456	CbGbCtD
Etoposide—ABCG2—Rosuvastatin—atherosclerosis	0.0283	0.0453	CbGbCtD
Etoposide—ABCG2—Ezetimibe—atherosclerosis	0.0283	0.0453	CbGbCtD
Etoposide—ABCG2—Pravastatin—atherosclerosis	0.0257	0.0412	CbGbCtD
Etoposide—CYP3A5—Rosuvastatin—atherosclerosis	0.0157	0.0251	CbGbCtD
Etoposide—CYP3A5—Simvastatin—atherosclerosis	0.0146	0.0233	CbGbCtD
Etoposide—CYP3A5—Pravastatin—atherosclerosis	0.0142	0.0228	CbGbCtD
Etoposide—CYP3A5—Lovastatin—atherosclerosis	0.0142	0.0228	CbGbCtD
Etoposide—CYP2C8—Simvastatin—atherosclerosis	0.014	0.0224	CbGbCtD
Etoposide—CYP2C8—Pravastatin—atherosclerosis	0.0137	0.022	CbGbCtD
Etoposide—CYP2C8—Lovastatin—atherosclerosis	0.0137	0.022	CbGbCtD
Etoposide—ABCB1—Ezetimibe—atherosclerosis	0.0102	0.0163	CbGbCtD
Etoposide—ABCB1—Simvastatin—atherosclerosis	0.00947	0.0152	CbGbCtD
Etoposide—ABCB1—Lovastatin—atherosclerosis	0.00927	0.0149	CbGbCtD
Etoposide—ABCB1—Pravastatin—atherosclerosis	0.00927	0.0149	CbGbCtD
Etoposide—CYP3A4—Rosuvastatin—atherosclerosis	0.0061	0.00979	CbGbCtD
Etoposide—CYP3A4—Ezetimibe—atherosclerosis	0.0061	0.00979	CbGbCtD
Etoposide—CYP3A4—Simvastatin—atherosclerosis	0.00567	0.0091	CbGbCtD
Etoposide—CYP3A4—Pravastatin—atherosclerosis	0.00555	0.00891	CbGbCtD
Etoposide—CYP3A4—Lovastatin—atherosclerosis	0.00555	0.00891	CbGbCtD
Etoposide—TOP2B—Pitavastatin—Rosuvastatin—atherosclerosis	0.00216	0.634	CbGdCrCtD
Etoposide—PTGS2—leg—atherosclerosis	0.00126	0.0516	CbGeAlD
Etoposide—PTGS2—hindlimb—atherosclerosis	0.00113	0.0461	CbGeAlD
Etoposide—GSTT1—cardiovascular system—atherosclerosis	0.00112	0.0456	CbGeAlD
Etoposide—ABCC6—connective tissue—atherosclerosis	0.00104	0.0425	CbGeAlD
Etoposide—PTGS2—appendage—atherosclerosis	0.000968	0.0395	CbGeAlD
Etoposide—TOP2B—connective tissue—atherosclerosis	0.000946	0.0386	CbGeAlD
Etoposide—ABCC6—cardiovascular system—atherosclerosis	0.000907	0.037	CbGeAlD
Etoposide—TOP2B—cardiovascular system—atherosclerosis	0.000823	0.0336	CbGeAlD
Etoposide—ABCC6—adipose tissue—atherosclerosis	0.0008	0.0326	CbGeAlD
Etoposide—TOP2B—adipose tissue—atherosclerosis	0.000726	0.0296	CbGeAlD
Etoposide—PTGS1—artery—atherosclerosis	0.000724	0.0295	CbGeAlD
Etoposide—PTGS2—artery—atherosclerosis	0.000692	0.0282	CbGeAlD
Etoposide—GSTT1—liver—atherosclerosis	0.000691	0.0282	CbGeAlD
Etoposide—PTGS1—endothelium—atherosclerosis	0.000611	0.0249	CbGeAlD
Etoposide—GSTP1—connective tissue—atherosclerosis	0.000592	0.0242	CbGeAlD
Etoposide—PTGS2—endothelium—atherosclerosis	0.000584	0.0238	CbGeAlD
Etoposide—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000564	0.00539	CcSEcCtD
Etoposide—PTGS1—blood vessel—atherosclerosis	0.000564	0.023	CbGeAlD
Etoposide—ABCC6—liver—atherosclerosis	0.000561	0.0229	CbGeAlD
Etoposide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000561	0.00535	CcSEcCtD
Etoposide—Cramp muscle—Simvastatin—atherosclerosis	0.000549	0.00524	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000549	0.00524	CcSEcCtD
Etoposide—PTGS2—blood vessel—atherosclerosis	0.000539	0.022	CbGeAlD
Etoposide—TOP2A—adipose tissue—atherosclerosis	0.000534	0.0218	CbGeAlD
Etoposide—GSTP1—cardiovascular system—atherosclerosis	0.000515	0.021	CbGeAlD
Etoposide—TOP2B—liver—atherosclerosis	0.000509	0.0208	CbGeAlD
Etoposide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000498	0.00476	CcSEcCtD
Etoposide—Cramp muscle—Pravastatin—atherosclerosis	0.000496	0.00474	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000496	0.00474	CcSEcCtD
Etoposide—Infestation—Ezetimibe—atherosclerosis	0.000493	0.00471	CcSEcCtD
Etoposide—Infestation NOS—Ezetimibe—atherosclerosis	0.000493	0.00471	CcSEcCtD
Etoposide—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000492	0.0047	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000486	0.00464	CcSEcCtD
Etoposide—Dysphagia—Niacin—atherosclerosis	0.000484	0.00462	CcSEcCtD
Etoposide—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000483	0.00461	CcSEcCtD
Etoposide—Jaundice—Ezetimibe—atherosclerosis	0.00048	0.00459	CcSEcCtD
Etoposide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000466	0.00445	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000466	0.00445	CcSEcCtD
Etoposide—Sweating increased—Pravastatin—atherosclerosis	0.000464	0.00443	CcSEcCtD
Etoposide—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000461	0.0044	CcSEcCtD
Etoposide—Jaundice—Simvastatin—atherosclerosis	0.000458	0.00437	CcSEcCtD
Etoposide—ABCC3—adipose tissue—atherosclerosis	0.000456	0.0186	CbGeAlD
Etoposide—GSTP1—adipose tissue—atherosclerosis	0.000454	0.0185	CbGeAlD
Etoposide—ABCC10—adipose tissue—atherosclerosis	0.000454	0.0185	CbGeAlD
Etoposide—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.000429	0.126	CbGdCrCtD
Etoposide—Erythema multiforme—Lovastatin—atherosclerosis	0.000426	0.00407	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000421	0.00402	CcSEcCtD
Etoposide—Jaundice—Niacin—atherosclerosis	0.000421	0.00402	CcSEcCtD
Etoposide—Stomatitis—Niacin—atherosclerosis	0.000421	0.00402	CcSEcCtD
Etoposide—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000419	0.004	CcSEcCtD
Etoposide—Flushing—Lovastatin—atherosclerosis	0.000419	0.004	CcSEcCtD
Etoposide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000418	0.00399	CcSEcCtD
Etoposide—Myocardial infarction—Pravastatin—atherosclerosis	0.000416	0.00398	CcSEcCtD
Etoposide—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000416	0.00398	CcSEcCtD
Etoposide—Jaundice—Pravastatin—atherosclerosis	0.000414	0.00395	CcSEcCtD
Etoposide—Flushing—Ezetimibe—atherosclerosis	0.000411	0.00392	CcSEcCtD
Etoposide—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00041	0.12	CbGdCrCtD
Etoposide—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00041	0.12	CbGdCrCtD
Etoposide—UGT1A1—liver—atherosclerosis	0.000405	0.0165	CbGeAlD
Etoposide—Chills—Lovastatin—atherosclerosis	0.000405	0.00386	CcSEcCtD
Etoposide—Cough—Rosuvastatin—atherosclerosis	0.000404	0.00386	CcSEcCtD
Etoposide—Angiopathy—Ezetimibe—atherosclerosis	0.000401	0.00383	CcSEcCtD
Etoposide—Immune system disorder—Ezetimibe—atherosclerosis	0.0004	0.00382	CcSEcCtD
Etoposide—Erythema multiforme—Simvastatin—atherosclerosis	0.000399	0.00381	CcSEcCtD
Etoposide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000399	0.00381	CcSEcCtD
Etoposide—Alopecia—Lovastatin—atherosclerosis	0.000399	0.00381	CcSEcCtD
Etoposide—Flushing—Simvastatin—atherosclerosis	0.000392	0.00374	CcSEcCtD
Etoposide—Alopecia—Ezetimibe—atherosclerosis	0.000391	0.00373	CcSEcCtD
Etoposide—Hypoaesthesia—Niacin—atherosclerosis	0.000385	0.00368	CcSEcCtD
Etoposide—Dysgeusia—Lovastatin—atherosclerosis	0.000384	0.00367	CcSEcCtD
Etoposide—Confusional state—Rosuvastatin—atherosclerosis	0.000381	0.00364	CcSEcCtD
Etoposide—Back pain—Lovastatin—atherosclerosis	0.00038	0.00363	CcSEcCtD
Etoposide—Hypoaesthesia—Pravastatin—atherosclerosis	0.00038	0.00362	CcSEcCtD
Etoposide—Chills—Simvastatin—atherosclerosis	0.000379	0.00361	CcSEcCtD
Etoposide—Muscle spasms—Lovastatin—atherosclerosis	0.000377	0.0036	CcSEcCtD
Etoposide—Infection—Rosuvastatin—atherosclerosis	0.000376	0.00359	CcSEcCtD
Etoposide—Alopecia—Simvastatin—atherosclerosis	0.000373	0.00356	CcSEcCtD
Etoposide—Back pain—Ezetimibe—atherosclerosis	0.000373	0.00356	CcSEcCtD
Etoposide—Muscle spasms—Ezetimibe—atherosclerosis	0.00037	0.00354	CcSEcCtD
Etoposide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00037	0.00354	CcSEcCtD
Etoposide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000364	0.00348	CcSEcCtD
Etoposide—Eye disorder—Niacin—atherosclerosis	0.000362	0.00346	CcSEcCtD
Etoposide—Erythema multiforme—Pravastatin—atherosclerosis	0.000361	0.00344	CcSEcCtD
Etoposide—Dysgeusia—Simvastatin—atherosclerosis	0.00036	0.00343	CcSEcCtD
Etoposide—Flushing—Niacin—atherosclerosis	0.00036	0.00343	CcSEcCtD
Etoposide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000357	0.00341	CcSEcCtD
Etoposide—Anaemia—Ezetimibe—atherosclerosis	0.000356	0.0034	CcSEcCtD
Etoposide—Malaise—Lovastatin—atherosclerosis	0.000354	0.00338	CcSEcCtD
Etoposide—Flushing—Pravastatin—atherosclerosis	0.000354	0.00338	CcSEcCtD
Etoposide—Cardiac disorder—Pravastatin—atherosclerosis	0.000354	0.00338	CcSEcCtD
Etoposide—Muscle spasms—Simvastatin—atherosclerosis	0.000353	0.00337	CcSEcCtD
Etoposide—Vertigo—Lovastatin—atherosclerosis	0.000353	0.00337	CcSEcCtD
Etoposide—Angiopathy—Niacin—atherosclerosis	0.000351	0.00336	CcSEcCtD
Etoposide—Leukopenia—Lovastatin—atherosclerosis	0.000351	0.00336	CcSEcCtD
Etoposide—Chills—Niacin—atherosclerosis	0.000348	0.00332	CcSEcCtD
Etoposide—Malaise—Ezetimibe—atherosclerosis	0.000347	0.00332	CcSEcCtD
Etoposide—Alopecia—Niacin—atherosclerosis	0.000342	0.00327	CcSEcCtD
Etoposide—Chills—Pravastatin—atherosclerosis	0.000342	0.00327	CcSEcCtD
Etoposide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000341	0.00325	CcSEcCtD
Etoposide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00034	0.00324	CcSEcCtD
Etoposide—Anaemia—Simvastatin—atherosclerosis	0.000339	0.00324	CcSEcCtD
Etoposide—Alopecia—Pravastatin—atherosclerosis	0.000337	0.00322	CcSEcCtD
Etoposide—Cough—Ezetimibe—atherosclerosis	0.000336	0.00321	CcSEcCtD
Etoposide—Chest pain—Lovastatin—atherosclerosis	0.000334	0.00319	CcSEcCtD
Etoposide—ABCB1—blood vessel—atherosclerosis	0.000333	0.0136	CbGeAlD
Etoposide—Hypertension—Ezetimibe—atherosclerosis	0.000332	0.00317	CcSEcCtD
Etoposide—Malaise—Simvastatin—atherosclerosis	0.000331	0.00316	CcSEcCtD
Etoposide—Discomfort—Lovastatin—atherosclerosis	0.00033	0.00315	CcSEcCtD
Etoposide—Vertigo—Simvastatin—atherosclerosis	0.00033	0.00315	CcSEcCtD
Etoposide—Leukopenia—Simvastatin—atherosclerosis	0.000329	0.00314	CcSEcCtD
Etoposide—Chest pain—Ezetimibe—atherosclerosis	0.000328	0.00313	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000326	0.00311	CcSEcCtD
Etoposide—Dysgeusia—Pravastatin—atherosclerosis	0.000325	0.0031	CcSEcCtD
Etoposide—Muscle spasms—Niacin—atherosclerosis	0.000324	0.0031	CcSEcCtD
Etoposide—Discomfort—Ezetimibe—atherosclerosis	0.000324	0.00309	CcSEcCtD
Etoposide—Constipation—Rosuvastatin—atherosclerosis	0.000323	0.00309	CcSEcCtD
Etoposide—Pain—Rosuvastatin—atherosclerosis	0.000323	0.00309	CcSEcCtD
Etoposide—Confusional state—Lovastatin—atherosclerosis	0.000323	0.00309	CcSEcCtD
Etoposide—ABCC1—adipose tissue—atherosclerosis	0.000321	0.0131	CbGeAlD
Etoposide—Anaphylactic shock—Lovastatin—atherosclerosis	0.00032	0.00306	CcSEcCtD
Etoposide—ABCC3—liver—atherosclerosis	0.00032	0.0131	CbGeAlD
Etoposide—Muscle spasms—Pravastatin—atherosclerosis	0.000319	0.00305	CcSEcCtD
Etoposide—GSTP1—liver—atherosclerosis	0.000319	0.013	CbGeAlD
Etoposide—ABCC10—liver—atherosclerosis	0.000319	0.013	CbGeAlD
Etoposide—Infection—Lovastatin—atherosclerosis	0.000318	0.00304	CcSEcCtD
Etoposide—Confusional state—Ezetimibe—atherosclerosis	0.000317	0.00303	CcSEcCtD
Etoposide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000314	0.003	CcSEcCtD
Etoposide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000314	0.003	CcSEcCtD
Etoposide—Chest pain—Simvastatin—atherosclerosis	0.000313	0.00299	CcSEcCtD
Etoposide—Infection—Ezetimibe—atherosclerosis	0.000312	0.00298	CcSEcCtD
Etoposide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000312	0.00298	CcSEcCtD
Etoposide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000309	0.00295	CcSEcCtD
Etoposide—Discomfort—Simvastatin—atherosclerosis	0.000309	0.00295	CcSEcCtD
Etoposide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000308	0.00294	CcSEcCtD
Etoposide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000308	0.00294	CcSEcCtD
Etoposide—Anaemia—Pravastatin—atherosclerosis	0.000307	0.00293	CcSEcCtD
Etoposide—Anorexia—Lovastatin—atherosclerosis	0.000305	0.00292	CcSEcCtD
Etoposide—Skin disorder—Ezetimibe—atherosclerosis	0.000305	0.00292	CcSEcCtD
Etoposide—Vertigo—Niacin—atherosclerosis	0.000303	0.00289	CcSEcCtD
Etoposide—Confusional state—Simvastatin—atherosclerosis	0.000302	0.00289	CcSEcCtD
Etoposide—Leukopenia—Niacin—atherosclerosis	0.000302	0.00288	CcSEcCtD
Etoposide—Urticaria—Rosuvastatin—atherosclerosis	0.0003	0.00287	CcSEcCtD
Etoposide—Anaphylactic shock—Simvastatin—atherosclerosis	0.0003	0.00286	CcSEcCtD
Etoposide—Malaise—Pravastatin—atherosclerosis	0.000299	0.00286	CcSEcCtD
Etoposide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000299	0.00285	CcSEcCtD
Etoposide—Vertigo—Pravastatin—atherosclerosis	0.000298	0.00285	CcSEcCtD
Etoposide—Infection—Simvastatin—atherosclerosis	0.000298	0.00284	CcSEcCtD
Etoposide—Leukopenia—Pravastatin—atherosclerosis	0.000297	0.00284	CcSEcCtD
Etoposide—Loss of consciousness—Niacin—atherosclerosis	0.000296	0.00283	CcSEcCtD
Etoposide—Cough—Niacin—atherosclerosis	0.000294	0.00281	CcSEcCtD
Etoposide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000293	0.0028	CcSEcCtD
Etoposide—Cough—Pravastatin—atherosclerosis	0.00029	0.00277	CcSEcCtD
Etoposide—PTGS1—connective tissue—atherosclerosis	0.000289	0.0118	CbGeAlD
Etoposide—Paraesthesia—Lovastatin—atherosclerosis	0.000288	0.00275	CcSEcCtD
Etoposide—Hypertension—Pravastatin—atherosclerosis	0.000287	0.00274	CcSEcCtD
Etoposide—Anorexia—Simvastatin—atherosclerosis	0.000286	0.00273	CcSEcCtD
Etoposide—Dyspnoea—Lovastatin—atherosclerosis	0.000286	0.00273	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000285	0.00272	CcSEcCtD
Etoposide—Chest pain—Pravastatin—atherosclerosis	0.000283	0.0027	CcSEcCtD
Etoposide—Paraesthesia—Ezetimibe—atherosclerosis	0.000282	0.00269	CcSEcCtD
Etoposide—Dyspnoea—Ezetimibe—atherosclerosis	0.00028	0.00268	CcSEcCtD
Etoposide—Discomfort—Pravastatin—atherosclerosis	0.000279	0.00267	CcSEcCtD
Etoposide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000279	0.00266	CcSEcCtD
Etoposide—Decreased appetite—Lovastatin—atherosclerosis	0.000279	0.00266	CcSEcCtD
Etoposide—PTGS2—connective tissue—atherosclerosis	0.000276	0.0113	CbGeAlD
Etoposide—Fatigue—Lovastatin—atherosclerosis	0.000276	0.00264	CcSEcCtD
Etoposide—Anaphylactic shock—Niacin—atherosclerosis	0.000275	0.00263	CcSEcCtD
Etoposide—Constipation—Lovastatin—atherosclerosis	0.000274	0.00262	CcSEcCtD
Etoposide—Pain—Lovastatin—atherosclerosis	0.000274	0.00262	CcSEcCtD
Etoposide—Confusional state—Pravastatin—atherosclerosis	0.000273	0.00261	CcSEcCtD
Etoposide—Decreased appetite—Ezetimibe—atherosclerosis	0.000273	0.00261	CcSEcCtD
Etoposide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000271	0.00259	CcSEcCtD
Etoposide—Asthenia—Rosuvastatin—atherosclerosis	0.000271	0.00259	CcSEcCtD
Etoposide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000271	0.00259	CcSEcCtD
Etoposide—Fatigue—Ezetimibe—atherosclerosis	0.000271	0.00259	CcSEcCtD
Etoposide—Infection—Pravastatin—atherosclerosis	0.000269	0.00257	CcSEcCtD
Etoposide—Paraesthesia—Simvastatin—atherosclerosis	0.000269	0.00257	CcSEcCtD
Etoposide—Pain—Ezetimibe—atherosclerosis	0.000269	0.00257	CcSEcCtD
Etoposide—Constipation—Ezetimibe—atherosclerosis	0.000269	0.00257	CcSEcCtD
Etoposide—Tachycardia—Niacin—atherosclerosis	0.000269	0.00256	CcSEcCtD
Etoposide—Pruritus—Rosuvastatin—atherosclerosis	0.000268	0.00255	CcSEcCtD
Etoposide—Skin disorder—Niacin—atherosclerosis	0.000267	0.00255	CcSEcCtD
Etoposide—Dyspnoea—Simvastatin—atherosclerosis	0.000267	0.00255	CcSEcCtD
Etoposide—Hyperhidrosis—Niacin—atherosclerosis	0.000266	0.00254	CcSEcCtD
Etoposide—ABCG2—adipose tissue—atherosclerosis	0.000266	0.0109	CbGeAlD
Etoposide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000265	0.00253	CcSEcCtD
Etoposide—Feeling abnormal—Lovastatin—atherosclerosis	0.000264	0.00252	CcSEcCtD
Etoposide—Anorexia—Niacin—atherosclerosis	0.000262	0.0025	CcSEcCtD
Etoposide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000262	0.0025	CcSEcCtD
Etoposide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000262	0.0025	CcSEcCtD
Etoposide—CYP2E1—cardiovascular system—atherosclerosis	0.000261	0.0107	CbGeAlD
Etoposide—Decreased appetite—Simvastatin—atherosclerosis	0.000261	0.00249	CcSEcCtD
Etoposide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000259	0.00247	CcSEcCtD
Etoposide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000259	0.00247	CcSEcCtD
Etoposide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000259	0.00247	CcSEcCtD
Etoposide—Fatigue—Simvastatin—atherosclerosis	0.000258	0.00247	CcSEcCtD
Etoposide—Anorexia—Pravastatin—atherosclerosis	0.000258	0.00247	CcSEcCtD
Etoposide—Hypotension—Niacin—atherosclerosis	0.000257	0.00246	CcSEcCtD
Etoposide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000257	0.00245	CcSEcCtD
Etoposide—Constipation—Simvastatin—atherosclerosis	0.000256	0.00245	CcSEcCtD
Etoposide—Pain—Simvastatin—atherosclerosis	0.000256	0.00245	CcSEcCtD
Etoposide—ABCC2—liver—atherosclerosis	0.000256	0.0104	CbGeAlD
Etoposide—Urticaria—Lovastatin—atherosclerosis	0.000255	0.00243	CcSEcCtD
Etoposide—Body temperature increased—Lovastatin—atherosclerosis	0.000253	0.00242	CcSEcCtD
Etoposide—Abdominal pain—Lovastatin—atherosclerosis	0.000253	0.00242	CcSEcCtD
Etoposide—PTGS1—cardiovascular system—atherosclerosis	0.000252	0.0103	CbGeAlD
Etoposide—Dizziness—Rosuvastatin—atherosclerosis	0.00025	0.00239	CcSEcCtD
Etoposide—Urticaria—Ezetimibe—atherosclerosis	0.00025	0.00238	CcSEcCtD
Etoposide—Abdominal pain—Ezetimibe—atherosclerosis	0.000248	0.00237	CcSEcCtD
Etoposide—Body temperature increased—Ezetimibe—atherosclerosis	0.000248	0.00237	CcSEcCtD
Etoposide—Paraesthesia—Niacin—atherosclerosis	0.000247	0.00236	CcSEcCtD
Etoposide—Feeling abnormal—Simvastatin—atherosclerosis	0.000247	0.00236	CcSEcCtD
Etoposide—CYP3A5—adipose tissue—atherosclerosis	0.000247	0.0101	CbGeAlD
Etoposide—Dyspnoea—Niacin—atherosclerosis	0.000245	0.00234	CcSEcCtD
Etoposide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000245	0.00234	CcSEcCtD
Etoposide—Somnolence—Niacin—atherosclerosis	0.000245	0.00234	CcSEcCtD
Etoposide—Paraesthesia—Pravastatin—atherosclerosis	0.000243	0.00232	CcSEcCtD
Etoposide—Dyspnoea—Pravastatin—atherosclerosis	0.000242	0.00231	CcSEcCtD
Etoposide—PTGS2—cardiovascular system—atherosclerosis	0.00024	0.00981	CbGeAlD
Etoposide—Decreased appetite—Niacin—atherosclerosis	0.000239	0.00228	CcSEcCtD
Etoposide—Rash—Rosuvastatin—atherosclerosis	0.000238	0.00228	CcSEcCtD
Etoposide—Dermatitis—Rosuvastatin—atherosclerosis	0.000238	0.00227	CcSEcCtD
Etoposide—Urticaria—Simvastatin—atherosclerosis	0.000238	0.00227	CcSEcCtD
Etoposide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000238	0.00227	CcSEcCtD
Etoposide—Body temperature increased—Simvastatin—atherosclerosis	0.000237	0.00226	CcSEcCtD
Etoposide—Abdominal pain—Simvastatin—atherosclerosis	0.000237	0.00226	CcSEcCtD
Etoposide—Headache—Rosuvastatin—atherosclerosis	0.000237	0.00226	CcSEcCtD
Etoposide—Hypersensitivity—Lovastatin—atherosclerosis	0.000236	0.00225	CcSEcCtD
Etoposide—Decreased appetite—Pravastatin—atherosclerosis	0.000236	0.00225	CcSEcCtD
Etoposide—Pain—Niacin—atherosclerosis	0.000235	0.00225	CcSEcCtD
Etoposide—Fatigue—Pravastatin—atherosclerosis	0.000234	0.00223	CcSEcCtD
Etoposide—Constipation—Pravastatin—atherosclerosis	0.000232	0.00221	CcSEcCtD
Etoposide—Pain—Pravastatin—atherosclerosis	0.000232	0.00221	CcSEcCtD
Etoposide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000232	0.00221	CcSEcCtD
Etoposide—Asthenia—Lovastatin—atherosclerosis	0.00023	0.0022	CcSEcCtD
Etoposide—Pruritus—Lovastatin—atherosclerosis	0.000227	0.00216	CcSEcCtD
Etoposide—Asthenia—Ezetimibe—atherosclerosis	0.000226	0.00215	CcSEcCtD
Etoposide—ABCC1—liver—atherosclerosis	0.000225	0.00919	CbGeAlD
Etoposide—Gastrointestinal pain—Niacin—atherosclerosis	0.000225	0.00215	CcSEcCtD
Etoposide—Nausea—Rosuvastatin—atherosclerosis	0.000225	0.00214	CcSEcCtD
Etoposide—Feeling abnormal—Pravastatin—atherosclerosis	0.000223	0.00213	CcSEcCtD
Etoposide—Pruritus—Ezetimibe—atherosclerosis	0.000222	0.00212	CcSEcCtD
Etoposide—PTGS1—adipose tissue—atherosclerosis	0.000222	0.00905	CbGeAlD
Etoposide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000222	0.00212	CcSEcCtD
Etoposide—Hypersensitivity—Simvastatin—atherosclerosis	0.000221	0.00211	CcSEcCtD
Etoposide—Diarrhoea—Lovastatin—atherosclerosis	0.000219	0.00209	CcSEcCtD
Etoposide—Urticaria—Niacin—atherosclerosis	0.000219	0.00209	CcSEcCtD
Etoposide—Abdominal pain—Niacin—atherosclerosis	0.000218	0.00208	CcSEcCtD
Etoposide—Body temperature increased—Niacin—atherosclerosis	0.000218	0.00208	CcSEcCtD
Etoposide—Urticaria—Pravastatin—atherosclerosis	0.000215	0.00206	CcSEcCtD
Etoposide—Asthenia—Simvastatin—atherosclerosis	0.000215	0.00205	CcSEcCtD
Etoposide—Diarrhoea—Ezetimibe—atherosclerosis	0.000215	0.00205	CcSEcCtD
Etoposide—Body temperature increased—Pravastatin—atherosclerosis	0.000214	0.00205	CcSEcCtD
Etoposide—Abdominal pain—Pravastatin—atherosclerosis	0.000214	0.00205	CcSEcCtD
Etoposide—Pruritus—Simvastatin—atherosclerosis	0.000212	0.00202	CcSEcCtD
Etoposide—PTGS2—adipose tissue—atherosclerosis	0.000212	0.00865	CbGeAlD
Etoposide—Dizziness—Lovastatin—atherosclerosis	0.000212	0.00202	CcSEcCtD
Etoposide—Dizziness—Ezetimibe—atherosclerosis	0.000208	0.00198	CcSEcCtD
Etoposide—Diarrhoea—Simvastatin—atherosclerosis	0.000205	0.00196	CcSEcCtD
Etoposide—Vomiting—Lovastatin—atherosclerosis	0.000204	0.00195	CcSEcCtD
Etoposide—Hypersensitivity—Niacin—atherosclerosis	0.000203	0.00194	CcSEcCtD
Etoposide—Rash—Lovastatin—atherosclerosis	0.000202	0.00193	CcSEcCtD
Etoposide—Dermatitis—Lovastatin—atherosclerosis	0.000202	0.00193	CcSEcCtD
Etoposide—Headache—Lovastatin—atherosclerosis	0.000201	0.00192	CcSEcCtD
Etoposide—Vomiting—Ezetimibe—atherosclerosis	0.0002	0.00191	CcSEcCtD
Etoposide—Hypersensitivity—Pravastatin—atherosclerosis	0.0002	0.00191	CcSEcCtD
Etoposide—Dizziness—Simvastatin—atherosclerosis	0.000198	0.00189	CcSEcCtD
Etoposide—Rash—Ezetimibe—atherosclerosis	0.000198	0.00189	CcSEcCtD
Etoposide—Dermatitis—Ezetimibe—atherosclerosis	0.000198	0.00189	CcSEcCtD
Etoposide—Asthenia—Niacin—atherosclerosis	0.000197	0.00189	CcSEcCtD
Etoposide—Headache—Ezetimibe—atherosclerosis	0.000197	0.00188	CcSEcCtD
Etoposide—Pruritus—Niacin—atherosclerosis	0.000195	0.00186	CcSEcCtD
Etoposide—Asthenia—Pravastatin—atherosclerosis	0.000194	0.00186	CcSEcCtD
Etoposide—CYP2C8—liver—atherosclerosis	0.000192	0.00783	CbGeAlD
Etoposide—Pruritus—Pravastatin—atherosclerosis	0.000192	0.00183	CcSEcCtD
Etoposide—Vomiting—Simvastatin—atherosclerosis	0.000191	0.00182	CcSEcCtD
Etoposide—Nausea—Lovastatin—atherosclerosis	0.00019	0.00182	CcSEcCtD
Etoposide—Rash—Simvastatin—atherosclerosis	0.000189	0.0018	CcSEcCtD
Etoposide—Dermatitis—Simvastatin—atherosclerosis	0.000189	0.0018	CcSEcCtD
Etoposide—Diarrhoea—Niacin—atherosclerosis	0.000188	0.0018	CcSEcCtD
Etoposide—Headache—Simvastatin—atherosclerosis	0.000188	0.00179	CcSEcCtD
Etoposide—Nausea—Ezetimibe—atherosclerosis	0.000187	0.00178	CcSEcCtD
Etoposide—ABCG2—liver—atherosclerosis	0.000187	0.00761	CbGeAlD
Etoposide—Diarrhoea—Pravastatin—atherosclerosis	0.000185	0.00177	CcSEcCtD
Etoposide—Dizziness—Niacin—atherosclerosis	0.000182	0.00174	CcSEcCtD
Etoposide—CYP1A2—liver—atherosclerosis	0.00018	0.00732	CbGeAlD
Etoposide—Dizziness—Pravastatin—atherosclerosis	0.000179	0.00171	CcSEcCtD
Etoposide—Nausea—Simvastatin—atherosclerosis	0.000178	0.0017	CcSEcCtD
Etoposide—Vomiting—Niacin—atherosclerosis	0.000175	0.00167	CcSEcCtD
Etoposide—Rash—Niacin—atherosclerosis	0.000174	0.00166	CcSEcCtD
Etoposide—Dermatitis—Niacin—atherosclerosis	0.000173	0.00166	CcSEcCtD
Etoposide—CYP3A5—liver—atherosclerosis	0.000173	0.00706	CbGeAlD
Etoposide—Headache—Niacin—atherosclerosis	0.000172	0.00165	CcSEcCtD
Etoposide—Vomiting—Pravastatin—atherosclerosis	0.000172	0.00165	CcSEcCtD
Etoposide—Rash—Pravastatin—atherosclerosis	0.000171	0.00163	CcSEcCtD
Etoposide—Dermatitis—Pravastatin—atherosclerosis	0.000171	0.00163	CcSEcCtD
Etoposide—Headache—Pravastatin—atherosclerosis	0.00017	0.00162	CcSEcCtD
Etoposide—Nausea—Niacin—atherosclerosis	0.000163	0.00156	CcSEcCtD
Etoposide—CYP2E1—liver—atherosclerosis	0.000161	0.00659	CbGeAlD
Etoposide—Nausea—Pravastatin—atherosclerosis	0.000161	0.00154	CcSEcCtD
Etoposide—ABCB1—cardiovascular system—atherosclerosis	0.000149	0.00607	CbGeAlD
Etoposide—PTGS2—liver—atherosclerosis	0.000149	0.00607	CbGeAlD
Etoposide—ABCB1—adipose tissue—atherosclerosis	0.000131	0.00535	CbGeAlD
Etoposide—CYP3A4—liver—atherosclerosis	0.00013	0.0053	CbGeAlD
Etoposide—ABCB1—liver—atherosclerosis	9.2e-05	0.00375	CbGeAlD
Etoposide—ABCB1—Metabolism—LIPC—atherosclerosis	5.67e-06	5.51e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PRKCG—atherosclerosis	5.67e-06	5.5e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARA—atherosclerosis	5.66e-06	5.49e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOC3—atherosclerosis	5.64e-06	5.47e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—LDLR—atherosclerosis	5.6e-06	5.44e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—MTHFR—atherosclerosis	5.54e-06	5.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BGN—atherosclerosis	5.52e-06	5.36e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—atherosclerosis	5.51e-06	5.35e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CG—atherosclerosis	5.51e-06	5.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.48e-06	5.32e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AGT—atherosclerosis	5.48e-06	5.32e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CETP—atherosclerosis	5.47e-06	5.31e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOA5—atherosclerosis	5.47e-06	5.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FABP4—atherosclerosis	5.46e-06	5.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LCAT—atherosclerosis	5.46e-06	5.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS3—atherosclerosis	5.46e-06	5.3e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARA—atherosclerosis	5.43e-06	5.27e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—INS—atherosclerosis	5.4e-06	5.24e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.37e-06	5.21e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—APOE—atherosclerosis	5.37e-06	5.21e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOA4—atherosclerosis	5.36e-06	5.2e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HMOX1—atherosclerosis	5.34e-06	5.18e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—atherosclerosis	5.33e-06	5.18e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CAV1—atherosclerosis	5.32e-06	5.16e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—atherosclerosis	5.31e-06	5.16e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.31e-06	5.15e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—APOA1—atherosclerosis	5.31e-06	5.15e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.26e-06	5.11e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AGT—atherosclerosis	5.26e-06	5.11e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.26e-06	5.11e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTHFR—atherosclerosis	5.25e-06	5.1e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SCARB1—atherosclerosis	5.24e-06	5.09e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—INS—atherosclerosis	5.21e-06	5.06e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.2e-06	5.05e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—APOE—atherosclerosis	5.16e-06	5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.15e-06	5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.14e-06	4.99e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.13e-06	4.97e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOB—atherosclerosis	5.12e-06	4.96e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PDGFB—atherosclerosis	5.11e-06	4.96e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CAV1—atherosclerosis	5.11e-06	4.96e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—APOA1—atherosclerosis	5.1e-06	4.95e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.08e-06	4.93e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.06e-06	4.91e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HMOX1—atherosclerosis	5.03e-06	4.88e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HMOX1—atherosclerosis	5.02e-06	4.87e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—atherosclerosis	4.99e-06	4.84e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—atherosclerosis	4.98e-06	4.83e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—atherosclerosis	4.96e-06	4.81e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMGCR—atherosclerosis	4.95e-06	4.8e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APOE—atherosclerosis	4.89e-06	4.74e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—LPL—atherosclerosis	4.88e-06	4.74e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.87e-06	4.72e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.85e-06	4.71e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CG—atherosclerosis	4.84e-06	4.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CAV1—atherosclerosis	4.84e-06	4.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APOA1—atherosclerosis	4.83e-06	4.69e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOB—atherosclerosis	4.82e-06	4.67e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOB—atherosclerosis	4.81e-06	4.66e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—atherosclerosis	4.78e-06	4.64e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GPX1—atherosclerosis	4.77e-06	4.62e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NOS3—atherosclerosis	4.74e-06	4.6e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.7e-06	4.56e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—atherosclerosis	4.68e-06	4.55e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—atherosclerosis	4.68e-06	4.54e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—atherosclerosis	4.67e-06	4.54e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—atherosclerosis	4.65e-06	4.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CD36—atherosclerosis	4.64e-06	4.5e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.61e-06	4.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOA2—atherosclerosis	4.61e-06	4.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.61e-06	4.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.61e-06	4.48e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—LPL—atherosclerosis	4.6e-06	4.46e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—LPL—atherosclerosis	4.59e-06	4.45e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—INS—atherosclerosis	4.59e-06	4.45e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NOS3—atherosclerosis	4.57e-06	4.43e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.56e-06	4.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.56e-06	4.42e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS2—atherosclerosis	4.56e-06	4.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.53e-06	4.4e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—LIPC—atherosclerosis	4.53e-06	4.39e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOC3—atherosclerosis	4.5e-06	4.37e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—atherosclerosis	4.49e-06	4.36e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GPX1—atherosclerosis	4.49e-06	4.35e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GPX1—atherosclerosis	4.48e-06	4.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—LDLR—atherosclerosis	4.47e-06	4.34e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ABCA1—atherosclerosis	4.41e-06	4.28e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—INS—atherosclerosis	4.41e-06	4.28e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LPA—atherosclerosis	4.4e-06	4.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTHFR—atherosclerosis	4.4e-06	4.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CETP—atherosclerosis	4.37e-06	4.24e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CD36—atherosclerosis	4.37e-06	4.24e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CD36—atherosclerosis	4.36e-06	4.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.35e-06	4.22e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—atherosclerosis	4.34e-06	4.21e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—atherosclerosis	4.34e-06	4.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARA—atherosclerosis	4.31e-06	4.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BGN—atherosclerosis	4.26e-06	4.14e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOA5—atherosclerosis	4.22e-06	4.09e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—atherosclerosis	4.2e-06	4.08e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.18e-06	4.06e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—atherosclerosis	4.18e-06	4.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AGT—atherosclerosis	4.18e-06	4.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—INS—atherosclerosis	4.18e-06	4.05e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOB—atherosclerosis	4.16e-06	4.04e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—atherosclerosis	4.14e-06	4.02e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—atherosclerosis	4.13e-06	4.01e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOE—atherosclerosis	4.09e-06	3.97e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.07e-06	3.95e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARA—atherosclerosis	4.06e-06	3.94e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.06e-06	3.94e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CAV1—atherosclerosis	4.06e-06	3.94e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARA—atherosclerosis	4.05e-06	3.93e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.05e-06	3.93e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOA1—atherosclerosis	4.05e-06	3.93e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—atherosclerosis	4.04e-06	3.92e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NOS3—atherosclerosis	4.02e-06	3.9e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—LPL—atherosclerosis	3.97e-06	3.86e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.95e-06	3.83e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AGT—atherosclerosis	3.93e-06	3.82e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AGT—atherosclerosis	3.93e-06	3.81e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.92e-06	3.81e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—atherosclerosis	3.89e-06	3.78e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPX1—atherosclerosis	3.88e-06	3.76e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NOS3—atherosclerosis	3.86e-06	3.75e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOE—atherosclerosis	3.85e-06	3.74e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOE—atherosclerosis	3.85e-06	3.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SERPINE1—atherosclerosis	3.84e-06	3.72e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CAV1—atherosclerosis	3.82e-06	3.71e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CAV1—atherosclerosis	3.81e-06	3.7e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOA1—atherosclerosis	3.81e-06	3.7e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOA1—atherosclerosis	3.8e-06	3.69e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMOX1—atherosclerosis	3.79e-06	3.67e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CD36—atherosclerosis	3.78e-06	3.66e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—atherosclerosis	3.72e-06	3.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—atherosclerosis	3.69e-06	3.59e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—atherosclerosis	3.68e-06	3.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS3—atherosclerosis	3.66e-06	3.55e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOB—atherosclerosis	3.63e-06	3.52e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—atherosclerosis	3.61e-06	3.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.58e-06	3.47e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—atherosclerosis	3.57e-06	3.46e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.56e-06	3.46e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—atherosclerosis	3.53e-06	3.43e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—atherosclerosis	3.53e-06	3.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.52e-06	3.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.52e-06	3.41e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARA—atherosclerosis	3.51e-06	3.41e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—INS—atherosclerosis	3.5e-06	3.39e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LIPC—atherosclerosis	3.5e-06	3.39e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—atherosclerosis	3.48e-06	3.37e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOC3—atherosclerosis	3.47e-06	3.37e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.47e-06	3.37e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—LPL—atherosclerosis	3.46e-06	3.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LDLR—atherosclerosis	3.45e-06	3.35e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AGT—atherosclerosis	3.4e-06	3.3e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPX1—atherosclerosis	3.38e-06	3.28e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CETP—atherosclerosis	3.37e-06	3.27e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—atherosclerosis	3.36e-06	3.26e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—atherosclerosis	3.35e-06	3.25e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOE—atherosclerosis	3.33e-06	3.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAV1—atherosclerosis	3.3e-06	3.2e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOA1—atherosclerosis	3.29e-06	3.2e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—INS—atherosclerosis	3.29e-06	3.19e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CD36—atherosclerosis	3.29e-06	3.19e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—INS—atherosclerosis	3.29e-06	3.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.23e-06	3.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—atherosclerosis	3.21e-06	3.11e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—atherosclerosis	3.12e-06	3.02e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NOS3—atherosclerosis	3.07e-06	2.98e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARA—atherosclerosis	3.06e-06	2.97e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.05e-06	2.96e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.02e-06	2.93e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—atherosclerosis	3.02e-06	2.93e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—atherosclerosis	3.01e-06	2.92e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.01e-06	2.92e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AGT—atherosclerosis	2.96e-06	2.87e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOE—atherosclerosis	2.9e-06	2.82e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—atherosclerosis	2.9e-06	2.82e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOB—atherosclerosis	2.89e-06	2.81e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NOS3—atherosclerosis	2.89e-06	2.8e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NOS3—atherosclerosis	2.88e-06	2.8e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAV1—atherosclerosis	2.88e-06	2.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOA1—atherosclerosis	2.87e-06	2.78e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—INS—atherosclerosis	2.85e-06	2.76e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.82e-06	2.73e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—LPL—atherosclerosis	2.76e-06	2.68e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—atherosclerosis	2.72e-06	2.64e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.72e-06	2.64e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPX1—atherosclerosis	2.7e-06	2.62e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—atherosclerosis	2.68e-06	2.6e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.64e-06	2.56e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.64e-06	2.56e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CD36—atherosclerosis	2.63e-06	2.55e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.62e-06	2.54e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—atherosclerosis	2.61e-06	2.54e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—atherosclerosis	2.61e-06	2.53e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—atherosclerosis	2.53e-06	2.45e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—atherosclerosis	2.51e-06	2.43e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—atherosclerosis	2.5e-06	2.42e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NOS3—atherosclerosis	2.5e-06	2.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.49e-06	2.41e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—INS—atherosclerosis	2.48e-06	2.41e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARA—atherosclerosis	2.44e-06	2.37e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—atherosclerosis	2.42e-06	2.35e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AGT—atherosclerosis	2.36e-06	2.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.33e-06	2.26e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOE—atherosclerosis	2.32e-06	2.25e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAV1—atherosclerosis	2.3e-06	2.23e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOA1—atherosclerosis	2.29e-06	2.22e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.28e-06	2.21e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—atherosclerosis	2.27e-06	2.21e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOB—atherosclerosis	2.23e-06	2.17e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—atherosclerosis	2.18e-06	2.11e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NOS3—atherosclerosis	2.17e-06	2.11e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.17e-06	2.11e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LPL—atherosclerosis	2.13e-06	2.07e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—atherosclerosis	2.1e-06	2.04e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.09e-06	2.03e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPX1—atherosclerosis	2.08e-06	2.02e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CD36—atherosclerosis	2.03e-06	1.97e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—atherosclerosis	2.02e-06	1.96e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—atherosclerosis	1.99e-06	1.93e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—INS—atherosclerosis	1.98e-06	1.92e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.92e-06	1.86e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARA—atherosclerosis	1.88e-06	1.83e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—atherosclerosis	1.85e-06	1.79e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AGT—atherosclerosis	1.82e-06	1.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—atherosclerosis	1.82e-06	1.77e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—atherosclerosis	1.81e-06	1.76e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOE—atherosclerosis	1.79e-06	1.73e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—atherosclerosis	1.78e-06	1.72e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.77e-06	1.72e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.77e-06	1.72e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NOS3—atherosclerosis	1.74e-06	1.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—atherosclerosis	1.68e-06	1.63e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.61e-06	1.57e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.59e-06	1.54e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—atherosclerosis	1.56e-06	1.51e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—INS—atherosclerosis	1.53e-06	1.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—atherosclerosis	1.41e-06	1.37e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—atherosclerosis	1.4e-06	1.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NOS3—atherosclerosis	1.34e-06	1.3e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—atherosclerosis	1.33e-06	1.29e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—atherosclerosis	1.32e-06	1.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.23e-06	1.19e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—atherosclerosis	1.15e-06	1.11e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—atherosclerosis	9.99e-07	9.7e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—atherosclerosis	7.98e-07	7.74e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—atherosclerosis	6.16e-07	5.97e-06	CbGpPWpGaD
